Eslicarbazepine Acetate
Back to searchMolecule Structure
Scientific Name
Eslicarbazepine Acetate
Description of the Drug
Eslicarbazepine acetate is an anticonvulsant agent used as an adjunct to treat partial-onset seizures in patients with inadequate clinical response to conventional antiepileptic therapy.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB09119
http://www.drugbank.ca/drugs/DB09119
Brand Name(s)
Aptiom, Erelib, Pazzul, Stedesa, Zebinix
Company Owner(s)
Sunovion Pharmaceuticals Inc, Dr Reddys Laboratories Ltd
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Sodium channel alpha subunit | PROTEIN FAMILY | BLOCKER | CHEMBL2331043 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL250594 | |
DrugBank | DB09119 | |
PubChem: Thomson Pharma | 14800284 | 14825046 |
PubChem | 179344 | |
Nikkaji | J1.143.147J | |
BindingDB | 50240669 | |
EPA CompTox Dashboard | DTXSID90178308 | |
DrugCentral | 4303 | |
ChemicalBook | CB5503197 | |
rxnorm | APTIOM | ESLICARBAZEPINE ACETATE |
PubChem: Drugs of the Future | 85197631 | |
ChEBI | 87016 | |
ZINC | ZINC000000007295 |